EMA Authorised: Tuyory — Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)

View source ↗

Summary

Tuyory has been authorised by the EMA for multiple indications including rheumatoid arthritis, juvenile arthritis, cytokine release syndrome, giant cell arterit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Infection
• Cytokine Release Syndrome
• Giant Cell Arteritis
• Juvenile Idiopathic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Tuyory

Snippet

Status: Authorised. Therapeutic area: Arthritis, Rheumatoid;Arthritis, Juvenile;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection. MAH: Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.). Decision date: 27/04/2026